Repligen Cp (RGEN) is trading 12% higher at $197.76 today.

Repligen Cp has been trading between a 52-week high of $327.32 and a 52-week low of $137.21. The stock has a market cap of $10.8 Billion.

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide.

Repligen attracts initial bull rating at UBS Group on long-term growth prospects
Seeking Alpha 07-20-22

Repligen Corporation (NASDAQ: RGEN) Is Down -35.80% So Far This Year: What Will Happen Next?
Stocks Register 05-30-22

Repligen Corporation to Present at Upcoming Investor Conferences
GlobeNewswire 05-25-22

Revisiting Repligen Stock (NASDAQ:RGEN)
Seeking Alpha 05-11-22

Repligen Corporation (NASDAQ: RGEN) Has Fallen -108.52% From Its Highs, What Comes Next?
Marketing Sentinel 05-07-22